# Effect of Insulin Staging in the Context of Pharmaceutical Care on Patients With Type 2 Diabetes Mellitus

> **NCT05244200** · NA · UNKNOWN · sponsor: **University of Sulaimani** · enrollment: 100 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **OTHER:** Pharmaceutical care and insulin staging.

## Key facts

- **NCT ID:** NCT05244200
- **Lead sponsor:** University of Sulaimani
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-20
- **Primary completion:** 2022-10-01
- **Final completion:** 2022-11-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05244200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05244200, "Effect of Insulin Staging in the Context of Pharmaceutical Care on Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05244200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*